# FDA Inspection 1177220 - Provepharm Inc. - April 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/provepharm-inc/6df5a52c-4165-41d1-a4f4-5897bb8b3773
Source feed: FDA_Inspections

> FDA Inspection 1177220 for Provepharm Inc. on April 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1177220
- Company Name: Provepharm Inc.
- Inspection Date: 2022-04-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1240960 - 2024-04-05](https://www.keypedia.com/records/fda_inspections/provepharm-inc/2411702f-3d84-4cd4-88f3-2fe15953999f)

Company: https://www.keypedia.com/companies/provepharm-inc/cdc07e6d-a59c-41de-9eab-91ecf43f5387

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c